BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27258774)

  • 41. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients.
    Nikaein A; Cherikh W; Nelson K; Baker T; Leffell S; Bow L; Crowe D; Connick K; Head MA; Kamoun M; Kimball P; Klohe E; Noreen H; Rebellato L; Sell T; Sullivan K; Land G
    Transplantation; 2009 Feb; 87(4):557-62. PubMed ID: 19307794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens.
    Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM
    Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
    Rose ML; Smith JD
    Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibody monitoring system to support the single-antigen Luminex assay in donor-specific antibody detection.
    Hwang HS; Sun IO; Yoon HE; Choi BS; Oh EJ; Kim JI; Moon IS; Kim YS; Yang CW
    Hum Immunol; 2012 Apr; 73(4):370-5. PubMed ID: 22342452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.
    Delgado JC; Eckels DD
    Exp Mol Pathol; 2008 Aug; 85(1):59-63. PubMed ID: 18499103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein A-Based Immunoadsorption Is More Efficient Than Conventional Plasma Exchange to Remove Circulating Anti-HLA Antibodies.
    Maillard N; Absi L; Claisse G; Masson I; Alamartine E; Mariat C
    Blood Purif; 2015; 40(2):167-72. PubMed ID: 26278703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation analysis between virtual and Complement-Dependent-Cytotoxicity crossmatch in a monocenter retrospective series of 118 allografted patients.
    Crocchiolo R; Lo Po' S; Lumia D; Lando G; Cornacchini G; Crucitti L; Pugliano MT; Volpato E; Cuppari I; Sommaruga E; Pipitone MG; Labate S; Grillo G; Zucchetti E; Rossini S
    Curr Res Transl Med; 2021 May; 69(2):103287. PubMed ID: 33765638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Five years' experience at one centre with protein A immunoadsorption in patients with deleterious allo/autoantibodies (anti-HLA antibodies, autoimmune bleeding disorders) and post-transplant patients relapsing with focal glomerular sclerosis.
    Kriaa F; Laurian Y; Hiesse C; Tchernia G; Charpentier B
    Nephrol Dial Transplant; 1995; 10 Suppl 6():108-10. PubMed ID: 8524477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
    Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Beltran Catalan S; Avila Bernabeu A; Crespo Albiach J; Montoro JA; Pallardo Mateu LM
    Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
    Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
    Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver transplantation with a strongly positive crossmatch: case study and literature review.
    Leonard GR; Shike H; Uemura T; Gaspari JL; Ruggiero FM; Shah RA; Riley TR; Kadry Z
    Liver Transpl; 2013 Sep; 19(9):1001-10. PubMed ID: 23798324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hidden perils in a highly sensitized kidney transplant recipient.
    Ford S; Summers S; Cantwell L; Mulley W
    Nephrology (Carlton); 2012 Apr; 17 Suppl 1():9-11. PubMed ID: 22497647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients.
    Terasaka S; Kitada H; Okabe Y; Kawanami S; Noguchi H; Miyamoto K; Tsuchimoto A; Masutani K; Tanaka M
    Exp Clin Transplant; 2014 Jun; 12(3):227-32. PubMed ID: 24907723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using real data for a virtual crossmatch.
    Zachary AA; Sholander JT; Houp JA; Leffell MS
    Hum Immunol; 2009 Aug; 70(8):574-9. PubMed ID: 19527762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.
    Malheiro J; Tafulo S; Dias L; Martins LS; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
    Transpl Immunol; 2015 Mar; 32(2):66-71. PubMed ID: 25661873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection.
    Hirai T; Kohei N; Omoto K; Ishida H; Tanabe K
    Transpl Int; 2012 Sep; 25(9):925-34. PubMed ID: 22764746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.
    Jordan SC; Vo A; Bunnapradist S; Toyoda M; Peng A; Puliyanda D; Kamil E; Tyan D
    Transplantation; 2003 Aug; 76(4):631-6. PubMed ID: 12973100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of panel-reactive antibody in predicting crossmatch selection of cadaveric kidney recipients.
    Lieber SR; Perez FV; Tabossi MR; Persoli LB; Marques SB; Mazzali M; Alves-Filho G; de Souza CA
    Transplant Proc; 2007 Mar; 39(2):429-31. PubMed ID: 17362748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.